Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, providing promising breakthroughs throughout a variety of clinical and industrial applications. With its structural similarity to Normally derived human serum albumin, OsrHSA offers a safer, more reliable substitute for therapeutic u